| 注册
首页|期刊导航|中华医学杂志(英文版)|Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage Ⅰ and Ⅱ Nonsmall Cell Lung Cancer

Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage Ⅰ and Ⅱ Nonsmall Cell Lung Cancer

Yu-Ning Liu Xiao-Bing Wang Teng Wang Chao Zhang Kun-Peng Zhang Xiu-Yi Zhi Wei Zhang

中华医学杂志(英文版)2016,Vol.129Issue(17):2026-2032,7.
中华医学杂志(英文版)2016,Vol.129Issue(17):2026-2032,7.DOI:10.4103/0366-6999.189052

Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage Ⅰ and Ⅱ Nonsmall Cell Lung Cancer

Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage Ⅰ and Ⅱ Nonsmall Cell Lung Cancer

Yu-Ning Liu 1Xiao-Bing Wang 1Teng Wang 1Chao Zhang 1Kun-Peng Zhang 1Xiu-Yi Zhi 1Wei Zhang1

作者信息

  • 1. Department of Thoracic Surgery, Detection Center of Tumor Biology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • 折叠

摘要

关键词

Macrophage Inhibitory Cytokine-1/Nonsmall Cell Lung Cancer/Sensitivity/Specificity

Key words

Macrophage Inhibitory Cytokine-1/Nonsmall Cell Lung Cancer/Sensitivity/Specificity

引用本文复制引用

Yu-Ning Liu,Xiao-Bing Wang,Teng Wang,Chao Zhang,Kun-Peng Zhang,Xiu-Yi Zhi,Wei Zhang..Macrophage Inhibitory Cytokine-1 as a Novel Diagnostic and Prognostic Biomarker in Stage Ⅰ and Ⅱ Nonsmall Cell Lung Cancer[J].中华医学杂志(英文版),2016,129(17):2026-2032,7.

基金项目

This work was supported by grants from the National Natural Science Foundation of China (No.81502023 and No.81441080),National High-tech R&D Program (863Program) (No.2008AA02Z415),and Capital Characteristic clinic projects(No.Z12110700102066). (No.81502023 and No.81441080)

中华医学杂志(英文版)

OACSCDCSTPCDMEDLINESCI

0366-6999

访问量0
|
下载量0
段落导航相关论文